MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 233 filers reported holding MYRIAD GENETICS INC in Q4 2015. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $52,000 | +36.8% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $38,000 | +15.2% | 2,000 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $33,000 | +43.5% | 2,000 | +75.6% | 0.01% | +33.3% |
| Q3 2016 | $23,000 | +15.0% | 1,139 | +78.2% | 0.01% | +20.0% |
| Q2 2016 | $20,000 | -16.7% | 639 | 0.0% | 0.01% | -28.6% |
| Q1 2016 | $24,000 | -14.3% | 639 | 0.0% | 0.01% | -12.5% |
| Q4 2015 | $28,000 | +16.7% | 639 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $24,000 | +41.2% | 639 | +27.8% | 0.01% | +60.0% |
| Q2 2015 | $17,000 | -5.6% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $18,000 | +5.9% | 500 | 0.0% | 0.01% | +66.7% |
| Q4 2014 | $17,000 | -10.5% | 500 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $19,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $19,000 | +11.8% | 500 | 0.0% | 0.00% | +33.3% |
| Q1 2014 | $17,000 | +70.0% | 500 | 0.0% | 0.00% | +200.0% |
| Q4 2013 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |